|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 781.49 USD | -1.48% |
|
-5.59% | +1.25% |
| Market Cap | 7.8TCr 6.72TCr 6.37TCr 5.77TCr 11TCr 7,45500Cr 11TCr 76TCr 29TCr 3,79300Cr 29TCr 29TCr 11,98500Cr | P/E 2026 * |
18.1x | P/E 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 7.09TCr 6.11TCr 5.78TCr 5.24TCr 9.83TCr 6,77000Cr 9.88TCr 69TCr 26TCr 3,44400Cr 27TCr 26TCr 10,88400Cr | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.68x |
| Free-Float |
71.06% | Yield 2026 * |
0.5% | Yield 2027 * | 0.56% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -1.48% | ||
| 1 week | -5.59% | ||
| Current month | -2.20% | ||
| 1 month | -2.07% | ||
| 3 months | +27.67% | ||
| 6 months | +4.67% | ||
| Current year | +1.25% |
| 1 week | 780.81 |  | 821.17 |
| 1 month | 779.08 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 02/09/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/08/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -5.59% | +39.55% | -6.16% | 7.8TCr | |
| +5.38% | -1.09% | +512.38% | +36.80% | 5.75TCr | |
| -1.42% | -4.24% | -19.59% | -38.20% | 5.74TCr | |
| -0.56% | -2.21% | -11.34% | +27.29% | 4.88TCr | |
| +1.93% | -2.37% | -0.87% | +149.45% | 4.55TCr | |
| +0.80% | -1.67% | +49.90% | -15.98% | 3.21TCr | |
| -1.47% | -4.17% | +46.17% | +89.12% | 2.46TCr | |
| -0.85% | -8.64% | -4.39% | +161.31% | 2.08TCr | |
| -0.09% | -3.61% | +62.49% | +98.37% | 1.57TCr | |
| -0.08% | -3.21% | +41.46% | +153.73% | 1.42TCr | |
| Average | +0.22% | -3.81% | +71.58% | +65.57% | 3.95TCr | |
| Weighted average by Cap. | +0.36% | -3.69% | +88.79% | +41.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.69TCr 1.46TCr 1.38TCr 1.25TCr 2.35TCr 1,61700Cr 2.36TCr 16TCr 6.31TCr 82TCr 6.36TCr 6.22TCr 2,60000Cr | 1.85TCr 1.59TCr 1.51TCr 1.37TCr 2.56TCr 1,76600Cr 2.58TCr 18TCr 6.89TCr 90TCr 6.94TCr 6.79TCr 2,83900Cr |
| Net income | 477.34Cr 411.27Cr 389.42Cr 352.97Cr 662.19Cr 46TCr 665.55Cr 4.63TCr 1.78TCr 23TCr 1.79TCr 1.75TCr 73TCr | 544.54Cr 469.17Cr 444.25Cr 402.66Cr 755.42Cr 52TCr 759.25Cr 5.28TCr 2.03TCr 26TCr 2.05TCr 2TCr 84TCr |
| Net Debt | -717.2Cr -617.94Cr -585.1Cr -530.34Cr -994.94Cr -69TCr -999.99Cr -6.95TCr -2.67TCr -35TCr -2.69TCr -2.63TCr -1,10100Cr | -1.01TCr -866.34Cr -820.31Cr -743.53Cr -1.39TCr -96TCr -1.4TCr -9.74TCr -3.75TCr -49TCr -3.78TCr -3.69TCr -1,54400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $781.49 | -1.48% | 4,43,986 |
| 10/26/10 | $793.26 | -1.78% | 5,26,911 |
| 09/26/09 | $807.65 | -0.33% | 6,21,458 |
| 08/26/08 | $810.31 | -2.10% | 5,56,536 |
| 04/26/04 | $827.72 | -1.87% | 5,61,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
